SB 475 creates a framework for Pennsylvania courts to establish specialized "problem-solving" treatment courts (including veterans, drug, mental health, and DUI courts) and modifies probation rules. It allows courts to create "veterans tracks" within existing treatment programs and requires judges to consider a defendant's employment status when sentencing for technical probation violations. The bill specifically permits up to 30 days of incarceration to allow defendants to enter treatment courts instead of imposing full sentences for technical probation violations. This directly affects Pennsylvania courts, probation officers, and individuals on probation who commit minor violations.
HB 1527 updates the existing Rare Disease Advisory Council established in 2017, clarifying its structure and responsibilities. The bill directly affects patients with rare diseases and requires coordination among the Department of Health, Insurance Department, Department of Human Services, and Department of Education. Key provisions mandate the council to advise state agencies on rare disease research, treatment access, insurance coverage, and resource allocation. It also specifies how departments must collaborate on policies impacting rare disease patients, ensuring a unified state approach.
HB 309 amends Pennsylvania's Osteopathic Medical Practice Act (1978) to update licensing rules for osteopathic physicians and related healthcare providers. It changes registration requirements from annual to biennial (every two years), clarifies rules for visiting team physicians at sports events, and adjusts continuing medical education requirements. The bill directly affects licensed osteopathic physicians, nonresident practitioners, medical students, and healthcare facilities employing osteopathic staff. Signed into law on July 7, 2025 (Act No. 29), it streamlines administrative processes without creating new licensing barriers.
HB 1590 removes specific regulatory requirements that clinics must meet to receive payment for services provided within their own facilities under public assistance programs like Medicaid. This change directly affects clinics offering on-site care covered by these programs, simplifying their billing process. The bill amends the Human Services Code to eliminate the need for clinics to comply with certain prior payment rules when services occur inside their physical premises. It focuses solely on modifying reimbursement procedures without altering eligibility or funding levels.
HB 261 amends Pennsylvania's 1921 Insurance Company Law to update coverage rules for dependents and clarify community health definitions. It requires insurers to continue health coverage for unmarried children with intellectual or physical disabilities (who became disabled before age 19 and remain dependent) past age 19, provided policyholders submit proof within 31 days of the child's 19th birthday. The bill also revises "community health reinvestment activity" to explicitly include programs for preventing/treating intellectual disabilities and mental health services. These changes apply to policies issued after January 1, 1968, affecting insurers, employers offering group plans, and policyholders with disabled dependents. The law took effect immediately upon signing in June 2025.
SB 466 modifies Pennsylvania's fire and emergency medical services (EMS) grant programs and training requirements. It requires semiannual reports on grant recipients (including recipient names, amounts, and purposes) for federal disaster, homeland security, and public health funds, submitted to legislative leaders. The bill updates training standards to allow online/lecture/hands-on formats and integrates records into a certification system, while setting a 45-day application window and 60-day approval timeline for grants to fire and EMS companies. Crucially, it sets an expiration date of December 31, 2029, for the grant authority under these programs. The bill was enacted as Act No. 25 of 2025 on June 30, 2025.
HB 704 creates a new Neurodegenerative Disease Research Program and a dedicated funding mechanism within the Department of Health to support research on conditions like Alzheimer's and Parkinson's. The bill directs the Department of Health to manage the program and administer the Neurodegenerative Disease Research Program Fund, which will provide grants for scientific studies. This legislation directly affects researchers, medical institutions, and patients seeking treatments for neurodegenerative diseases by establishing a formal structure for funding and coordinating research efforts. The bill passed the legislature in June 2025 and is now pending final action by the Governor.
HB 409 amends Pennsylvania's Patient Test Result Information Act to require healthcare providers to give patients written notice at the time of diagnostic imaging services (like X-rays, MRIs, and ultrasounds) about how to access their results, including online portals or mail (with a possible fee for mailing). It also mandates a follow-up notice within 20 days if a significant abnormality is found, including details like the test date and ordering doctor's name, unless exceptions apply. Exceptions include routine obstetrical ultrasounds, inpatient or emergency care, diagnostic radiographs (X-rays), and patients with chronic conditions who were previously notified. This bill directly affects patients receiving diagnostic imaging and the healthcare facilities performing these services.
HB 707 amends Pennsylvania's Freedom to Breastfeed Act to require all Commonwealth-owned buildings (like state offices, courthouses, and the State Museum) to provide dedicated nursing parent rooms. These rooms must be at least 50 square feet, lockable, accessible, and include essentials like a chair, work surface, sink, refrigerator, and privacy. The Department of General Services must install signage, maintain a public online list of room locations, and ensure compliance with accessibility standards. This directly affects employees and the public using state buildings who need to breastfeed or express milk.
HB 33 amends Pennsylvania's Medical Marijuana Act to clarify definitions and strengthen oversight of testing labs and practitioners. It defines key terms like "independent laboratory" (requiring no ties to marijuana businesses) and "approved laboratory" (testing medical marijuana samples under department approval). The bill gives the Department of Health new authority to impose conditions on medical practitioners, such as limiting certifications or requiring supervision, to protect patient safety. These changes directly affect medical marijuana patients, healthcare providers who certify them, and labs testing products for quality and safety. The updates aim to improve accountability in the program through clearer rules for lab accreditation and practitioner oversight.
